PS31 | IICIMED

PS31

Br. J. Surg. 2023, 110, 1567-1569.

The threat of antimicrobial resistance in surgical care : the surgeon's role and ownership of antimicrobial stewardship.

Birgand, G. | Dhar, P. | Holmes, A.

https://doi.org/10.1093/bjs/znad302

PS30 | IICIMED

PS30

Pediart Infect Dis J 2023, 42(10):888-892.

Safety and Efficacy of Ceftaroline in Neonates With Staphylococcal Late-onset Sepsis: A Case Series Analysis.

Cailles, A. | Martin-Perceval, L. | Crémet, L. | Gély, L. | Ruellan, A.-L. | Verdier, M.-C. | Grégoire, M. | Flamant, C. | Guillouzouic, A. | Prot-Labarthe, S. | Butin, M. | Launay, E.

PS29 | IICIMED

PS29

J Antimicrob Chemother 2023, 78(3):853-854.

Comment on Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.

Benaboud, S. | Solas, C. | Bouchet, S. | Grégoire, M. | Lemaitre, F. | Venisse, N. | Lê, M. | Muret, P. | Parant, F. | Néant, N. | Boujaafar, S. | Lagoutte-Renosi, J. | Garraffo, R. | Peytavin, G.

https://doi.org/10.1093/jac/dkad009

PS28 | IICIMED

PS28

J Antimicrob Chemother 2023, 78(12):2919-2925.

Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.

Hervochon, C. | Hennart, B. | Leroy, A.-G. | Corvec, S. | Boutoille, D. | Senneville, E. | Sotto, A. | Illes, G. | Chavanet, P. | Dubée, V. | Bleibtreu, A. | De Carné, M.-C. | Talarmin, J.-P. | Revest, M. | Castan, B. | Bellouard, R. | Dailly, E. | Allorge, D. | Dinh, A. | Le Turnier, P. | Grégoire, M.

https://doi.org/10.1093/jac/dkad331

PS27 | IICIMED

PS27

Int J Antimicrob Agents 2023, 62(5):106960.

Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel.

Senneville, E. | Cuervo, G. | Grégoire, M. | Hidalgo-Tenorio, C. | Jehl, F. | Miro, J.-M. | Seaton, A. | Söderquist, B. | Soriano, A. | Thalhammer, F. | Pea, F.

https://doi.org/10.1016/j.ijantimicag.2023.106960

PS26 | IICIMED

PS26

Br J Clin Pharmacol 2023.

Therapeutic drug monitoring and virological response at week 48 in a cohort ofHIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER Study). 

Lemaitre, F. | Lagoutte-Renosi, J. | Gagnieu, M.-C. | Parant, F. | Venisse, N. | Grégoire, M. | Bouchet, S. | Garraffo, R. | Lê, M.-P. | Muret, P. | Comets, E. | Solas, C. | Peytavin, G.

https://doi.org/10.1111/bcp.15890

PS25 | IICIMED

PS25

J Antimicrob Chemother 2023, dkad094.

A multifaceted strategy to optimize pharmacokinetics of antimicrobial therapy in patients with hospital-acquired infections—a monocentre quality improvement project.

Lagarde, C. | Bouras, M. | Le Floch, R. | Hourmant, Y. | Grillot, N. | Bourdiol, A. | Mahé, P.-J. | Deumeure Dit Latte, D. | Grégoire, M. | Dailly, E. | Bellouard, R. | Asehnoune, K. | Cinotti, R. | Roquilly, A.

https://doi.org/10.1093/jac/dkad094

PS24 | IICIMED

PS24

J Antimicrob Chemother 2023, 8, 965-974.

Development and validation of a dosing nomogram for continuous infusion cloxacillin in infective endocarditis.

Bellouard, R. | Rambaud, A. | Delaunay, C. | Dailly, E. | Lecomte, R. | Deschanvres, C. | Leroy, A.-G. | Boutoille, D. | Le Turnier, P. | Grégoire, M.

https://doi.org/10.1093/jac/dkad030

PS23 | IICIMED

PS23

Antibiotics 2023, 12, 123.

Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric Approach.

Coste, A. | Bellouard, R. | Deslandes, G. | Jalin, L. | Roger, C. | Ansart, S. | Dailly, E. | Bretonnière, C. | Grégoire, M.

https://doi.org/10.3390/antibiotics12010123

PS22 | IICIMED

PS22

Molbank, 2023 

Potassium 6-oxo-7,13,16,22-tetraazatetracyclo[12.6.2.18,12.017,21]tricosa-1(20),8(23), 9,11,14,16,18,21-octaen-2-yne-15-carboxylate.

Blouet, C. | Letast, S. | Robert, T. | Bach, S. | Pinaud, N. | Joubert, N. | Viaud-Massuard, M.-C. | Guillon, J. | Logé, C. | Denevault-Sabourin, C.

https://doi.org/10.3390/M1735

PS21 | IICIMED

PS21

BJS, 2023, 110, 1567–1569.

The threat of antimicrobial resistance in surgical care: the surgeon’s role and ownership of antimicrobial stewardship.

Birgand, G. | Dhar, P. | Holmes, A.

https://doi.org/10.1093/bjs/znad302

PS20 | IICIMED

Clustering and phenotyping of GZMB+Bregs. Schematic view of the study design from the cell preparation for scRNAseq.

PS20

Front. Immunol. 2023, 14, 1183714. 

Human granzyme B regulatory B cells prevent effector CD4+CD25- T cell proliferation through a mechanism dependent from lymphotoxin alpha.

Sailliet, N. | Mai H. L. | Dupuy, A. | Tilly, G. | Fourgeux, C. | Braud, M. | Giral, M. | Robert, J.-M. | Degauque, N. | Danger, R. | Poschmann, J. | Brouard, S.

https://doi.org/10.3389/fimmu.2023.1183714

PS19 | IICIMED

PS19

Viruses 2023, 15, 1783.

Arboviral risk associated with solid organ and hematopoietic stem cell grafts: The prophylactic answers proposed by the French High Council of Public Health in a national context.

Pozzetto, B. | Grard, G. | Durand, G. | Paty, M. C. | Gallian, P. | Lucas-Samuel, S. | Diéterlé, S. | Fromage, M. | Durand, M. | Lepelletier, D. | Chidiac, C. | Hoen B. | de Lamballerie X. N.

https://doi.org/10.3390/v15091783

PS18 | IICIMED

PS18

J. Hosp. Infect. 2023, 131, 58-69.

Role of antiseptics in the prevention and treatment of infections in nursing homes. 

Alves, P. J. | Gryson, L. | Hajjar, J. | Lepelletier, D. | Reners, M. | Rodríguez Salazar, J. | Simon, A.

https://doi.org/10.1016/j.jhin.2022.09.021

PS17 | IICIMED

PS17

Surg. Open Sci. 2023, 13, 9-17.

Evaluation of the role of povidone‑iodine in the prevention of surgical site infections. 

Monstrey, S. J. | Govaers, K. | Lejuste, P. | Lepelletier, D. | Ribeiro de Oliveira, P.

https://doi.org/10.1016/j.sopen.2023.03.005

PS16 | IICIMED

Deposition characteristics of speech droplets deposited from the 3-min “speaking activity”: large droplets in blue and small in red.

PS16

Food Microbiol. 2023, 114, 104297.

SARS-CoV-2 transmission modes: Why and how contamination occurs around shared meals and drinks? 

Saulnier, A. | Wendling, J. M. | Hermant, B. | Lepelletier, D.

https://doi.org/10.1016/j.fm.2023.104297

PS15 | IICIMED

Factors for and against De-escalating or Maintaining Universal Masking in Healthcare Centers.

PS15

Antimicrob. Steward Health Epidemiol. 2023, 3, e128. 

Considerations for de-escalating universal masking in healthcare centers.

Birgand, G. | Landelle, C. | Price, J. R. | Mutters, N. T. | Morgan, D. J. | Lucet, J. C. | Kerneis, S. | Zingg, W.

https://doi.org/10.1017/ash.2023.200

PS14 | IICIMED

PS14

Euro Surveill. 2023, 28, 2200718. 

Revisiting the personal protective equipment components of transmission-based precautions for the prevention of COVID-19 and other respiratory virus infections in healthcare.

Plachouras, D. | Kacelnik, O. | Rodríguez-Baño, J. | Birgand, G. | Borg, M. A. | Kristensen, B. | Kubele, J. | Lyytikäinen, O. | Presterl, E. | Reilly, J. | Voss, A. | Zingg, W. | Suetens, C. | Monnet, D. L.

https://doi.org/10.2807/1560-7917.ES.2023.28.32.2200718

PS13 | IICIMED

Incidence of COVID-19 in the Pays de la Loire region throughout the study period.

PS13

Front. Public Health 2023, 11, 1136980.

Social representations of mask wearing in the general population during the COVID-19 pandemic.

Bornand, E. | Letourneux, F. | Deschanvres, C. | Boutoille, D. | Lucet, J.-C. | Lepelletier, D. | Leclere, B. | Mayol, S. | Peiffer-Smadja, N. | Birgand, G.

https://doi.org/10.3389/fpubh.2023.1136980

PS12 | IICIMED

Rivaroxaban’s dosages at peak and trough, and evolution of serum albumin under direct oral anticoagulant therapy.

PS12

Nephrol. 2023, 36, 237-239.

Monitoring the activity of direct oral anticoagulants in a patient with severe nephrotic syndrome and pulmonary embolism. Lessons for the clinical nephrologist.

Laslandes, M. | Connault, J. | Nicolet, L. | Ternisien, C. | Gregoire, M. | Ville, S. | Dantal, J. | Masset, C.

https://doi.org/10.1007/s40620-022-01406-w